Comparison of biochemical markers of bone remodelling in the assessment of the effects of alendronate on bone in postmenopausal osteoporosis (Q73101767)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 October 1999

Language	Label	Description	Also known as
English	Comparison of biochemical markers of bone remodelling in the assessment of the effects of alendronate on bone in postmenopausal osteoporosis	scientific article published on 01 October 1999

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10529464%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Comparison of biochemical markers of bone remodelling in the assessment of the effects of alendronate on bone in postmenopausal osteoporosis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10529464%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

postmenopausal osteoporosis

1 reference

based on heuristic

inferred from title

Jan J. Štěpán

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10529464%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

J Vokrouhlická

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10529464%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 October 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10529464%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Clinica Chimica Acta

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10529464%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

288

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10529464%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

121-135

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10529464%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1-2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10529464%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

The diagnosis of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900151-5

7 January 2021

The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900151-5

7 January 2021

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900151-5

7 January 2021

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900151-5

7 January 2021

Alendronate Prevents Postmenopausal Bone Loss in Women without Osteoporosis: A Double-Blind, Randomized, Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900151-5

7 January 2021

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900151-5

7 January 2021

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900151-5

7 January 2021

A modified inactivation - inhibition method for determining the serum activity of alkaline phosphatase isoenzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900151-5

7 January 2021

Acute effects of calcium infusion on hydroxyproline

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900151-5

7 January 2021

High-performance liquid chromatographic analysis of urinary hydroxylysyl glycosides as indicators of collagen turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900151-5

7 January 2021

Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900151-5

7 January 2021

A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900151-5

7 January 2021

Identifiers

10.1016/S0009-8981(99)00151-5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10529464%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10529464%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73101767&oldid=1946827130"